Blueprint Medicines (BPMC) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BPMC is expected to report earnings to rise 23.56% to -98 cents per share on October 24

Blueprint Medicines BPMC Stock Earnings Reports

Q3'24

Est.

$-0.99

Q2'24

Beat

by $0.49

Q1'24

Beat

by $3.07

Q4'23

Beat

by $0.22

Q3'23

Beat

by $0.18

The last earnings report on August 01 showed earnings per share of -80 cents, beating the estimate of -128 cents. With 1.54M shares outstanding, the current market capitalization sits at 5.47B.

View a ticker or compare two or three

Compare

BPMC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BPMC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BPMC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of cancer therapies that harness the growing understanding of the molecular blueprint of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

45 Sidney Street

Phone

+1 617 374-7580

Employees

655

Web

https://www.blueprintmedicines.com